Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health and Social Care | ||||||||||
answering dept sort name | Health and Social Care | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Clinical Trials | ||||||||||
house id | 1 | ||||||||||
identifier | 187791 | ||||||||||
legislature |
|
||||||||||
parliament number | 58 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Health and Social Care, what assessment he has made of (a) the reasons for trends in the level of patients participating in clinical trials in England since 2018 and (b) the impact of financial incentives to GPs to enrol patients in clinical trials on levels of participation; whether he has had discussions with the (i) British Medical Association and (ii) Royal College of General Practitioners on this matter; how the amount paid per patient enrolled onto a clinical trial will be calculated; and whether measures will be put in place to ensure (A) patients (1) are able to give and (2) have given fully informed consent and (B) vulnerable patients are protected. | ||||||||||
session |
|
||||||||||
session number | 3 | ||||||||||
tabling member constituency | Kingston upon Hull West and Hessle | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2022/23 187791 | ||||||||||
type |
|
||||||||||
uin | 187791 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | NamedDay | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|